Ajushta Tablet 40/5 mg

Adult dose

The recommended dosage for adults is 1 tablet once a day, to be taken with water regardless of meals. It is advised to take it at the same time each day (e.g., in the morning). For patients with severe renal impairment, treatment should start at a lower dose and gradually increase. For patients with liver impairment, the daily dose of telmisartan should not exceed 40 mg. For elderly patients (75 years and older), treatment should start at a lower dose and adjust gradually.

Child dose

Safety and efficacy have not been established in pediatric patients under 18 years of age, so the administration of this medication is not recommended.

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with hypersensitivity, nursing mothers, patients with severe liver dysfunction, patients with severe cardiac disease, and patients with severe hypotension. Caution is advised for patients with decreased liver function, gastrointestinal diseases, renal dysfunction, and elderly patients when using this medication. Common side effects include dizziness or edema, and serious reactions related to the heart or kidneys may occur rarely. During pregnancy, the use of this medication can pose risks of decreased kidney function in the fetus, skull formation disorders, and hypotension in newborns, so it should be discontinued as quickly as possible. This medication may interact with other drugs, so caution is necessary, especially when co-administered with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. Nursing mothers are advised not to take this medication, and women planning to conceive should switch to another safer antihypertensive medication. The safety and efficacy of this medication have not been sufficiently established in children, so it is not recommended for pediatric use. Elderly patients may be more sensitive to this medication, and treatment should start at a lower dose, with gradual adjustments. Overdosing may cause symptoms such as hypotension, dizziness, and decreased cardiac function, so immediate medical attention is required. This medication should be kept out of reach of children and should not be transferred to another container; it should be taken immediately after opening the package. When driving or operating machinery, caution is needed as dizziness or drowsiness may occur after taking this medication.

Serious side effects

• Sepsis
• thrombocytopenia
• leukopenia
• anaphylactic reaction
• syncope
• myocardial infarction
• ventricular tachycardia
• arrhythmia
• atrial fibrillation
• vasculitis

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• cystitis
• anemia
• hypersensitivity reactions
• hyperkalemia
• hypoglycemia
• hyponatremia

This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is best to keep the medication at room temperature, between 1°C and 30°C, avoiding excessively hot or cold places.

Appearance

This is a biconvex, oval-shaped double tablet that is white and light gray.

Package unit

30 tablets (10 tablets/PTP X 3)